Quantification and Comprehensive Analysis of Mesenchymal Stromal Cells in Bone Marrow Samples from Sickle Cell Disease Patients with Osteonecrosis
The potential use of bone marrow mesenchymal stromal cells (BM-MSCs) for the treatment of osteonecrosis in sickle cell disease (SCD) patients is increasing. However, convenient BM-MSC quantification and functional property assays are critical factors for cell-based therapies yet to be optimized. Thi...
Saved in:
| Main Authors: | Tiago O. Ribeiro, Paula B. Daltro, Gildasio Cerqueira Daltro, Songeli M. Freire, Roberto Meyer, Vitor Fortuna |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2020/8841191 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD4+ T Cell Profile and Activation Response in Sickle Cell Disease Patients with Osteonecrosis
by: Paula B. Daltro, et al.
Published: (2020-01-01) -
Use of marrow multipotent mesenchymal (stromal) cells in renal transplantation
by: M. Sh. Khubutia, et al.
Published: (2021-06-01) -
To Breathe or Not to Breathe: The Role of Oxygen in Bone Marrow-Derived Mesenchymal Stromal Cell Senescence
by: Dhir Niren Gala, et al.
Published: (2021-01-01) -
Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia
by: Livia E. Lisi-Vega, et al.
Published: (2025-01-01) -
Vessel Wall-Derived Mesenchymal Stromal Cells Share Similar Differentiation Potential and Immunomodulatory Properties with Bone Marrow-Derived Stromal Cells
by: Zoltán Veréb, et al.
Published: (2020-01-01)